Jay Edelberg
Director/Board Member at Prolaio, Inc.
Jay Edelberg active positions
| Companies | Position | Start | End |
|---|---|---|---|
Prolaio, Inc.
 Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ. | Director/Board Member | - | - |
| Corporate Secretary | - | - |
Career history of Jay Edelberg
Former positions of Jay Edelberg
| Companies | Position | Start | End |
|---|---|---|---|
| MYOKARDIA, INC. | Chief Tech/Sci/R&D Officer | - | 2020-10-31 |
| SANOFI | Corporate Officer/Principal | - | - |
Training of Jay Edelberg
| Duke University | Doctorate Degree |
Statistics
International
| United States | 4 |
| France | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SANOFI | Commercial Services |
| Private companies | 2 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Prolaio, Inc.
Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ. | Health Technology |
- Stock Market
- Insiders
- Jay Edelberg
- Experience
